Does a single Pseudomonas aeruginosa isolation predict COPD mortality?
نویسندگان
چکیده
Denmark. Clin Respir J 2013; 7: 328–337. 3 Blanchette CM, Dalal AA, Mapel D. Changes in COPD demographics and costs over 20 years. J Med Econ 2012; 15: 1176–1182. 4 Corsonello A, Pedone C, Corica F, et al. Polypharmacy in elderly patients at discharge from the acute care hospital. Ther Clin Risk Manag 2007; 3: 197–203. 5 Hajjar ER, Hanlon JT, Artz MB, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 2003; 1: 82–89. 6 Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 2011; 9: 11–23. 7 Hovstadius B, Åstrand B, Persson U, et al. Acquisition cost of dispensed drugs in individuals with multiple medications – a register-based study in Sweden. Health Policy 2011; 101: 153–161. 8 Almagro P, López Garcı́a F, Cabrera FJ, et al. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med 2010; 104: 253–259. 9 Vestbo J, Hurd SS, Agustı́ AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347–365. 10 Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5: 345–351. 11 Nobili A, Marengoni A, Tettamanti M, et al. Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur J Intern Med 2011; 22: 597–602. 12 Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004; 351: 2870–2874. 13 Travers J, Marsh S, Caldwell B, et al. External validity of randomized controlled trials in COPD. Respir Med 2007; 101: 1313–1320. 14 Holmes HM. Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther 2009; 85: 103–107. 15 Cook DE, Sidel M, Belletti DA, et al. Review: clinical inertia in the management of chronic obstructive pulmonary disease. COPD 2012; 9: 73–80.
منابع مشابه
The existence of bronchiectasis predicts worse prognosis in patients with COPD
Bronchiectasis is prevalent in patients with COPD. The objective of this study was to assess the clinical characteristics and prognostic value of bronchiectasis in patients with COPD in China. Data from patients diagnosed with COPD at the Shanghai Pulmonary Hospital between January 2009 and December 2013 were retrospectively collected and analyzed. SPSS statistical software was used to analyze ...
متن کاملDoes a single Pseudomonas aeruginosa
Patients with chronic obstructive pulmonary disease (COPD) often suffer from acute exacerbations (AECOPD) of their disease, which have a significant impact on their health status [1]. Evidence suggests that ,50% of these exacerbations are attributable to bacteria [2]. Pseudomonas aeruginosa can cause AECOPD and is associated with reduced survival in cystic fibrosis (CF) and bronchiectasis [3, 4...
متن کاملPseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.
BACKGROUND Pseudomonas aeruginosa (PA) is isolated in advanced stages of chronic obstructive pulmonary disease (COPD). OBJECTIVES The aim of our study was to determine whether PA isolation during hospitalization for COPD exacerbation was associated with a poorer prognosis after discharge. METHODS We prospectively studied all patients with COPD exacerbation admitted between June 2003 and Sep...
متن کاملImportance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study
BACKGROUND Acute exacerbations of COPD (AECOPD) are often associated with infectious agents, some of which may be non-usual, including Aspergillus spp. However, the importance of Aspergillus spp. in the clinical management of AECOPD still remains unclear. OBJECTIVES The aims of the study were to analyze the prevalence and risk factors associated with Aspergillus spp. isolation in AECOPD, and ...
متن کاملPseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors
BACKGROUND Patients with severe chronic obstructive pulmonary disease (COPD) are at increased risk of infection by P. aeruginosa. The specific role of bronchiectasis in both infection and chronic colonization by this microorganism in COPD, however, remains ill defined.To evaluate the prevalence and risk factors for P. aeruginosa recovery from sputum in outpatients with severe COPD, characterizi...
متن کاملThe SENSOR Study: Protocol for a Mixed-Methods Study of Self-Management Checks to Predict Exacerbations of Pseudomonas Aeruginosa in Patients with Long-Term Respiratory Conditions
BACKGROUND There are an estimated three million people in the United Kingdom with chronic obstructive pulmonary disease (COPD), and the incidence of bronchiectasis is estimated at around 0.1% but is more common in COPD and severe asthma. Both COPD and bronchiectasis are characterized by exacerbations in which bacteria play a central role. Pseudomonas aeruginosa is isolated from sputum samples f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 44 شماره
صفحات -
تاریخ انتشار 2014